alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>  

PRICING SUPPLEMENT NO. 124 DATED                        Filed Pursuant to
SEPTEMBER 3, 1998 TO PROSPECTUS DATED                   Rule 424(b)(5)
SEPTEMBER 17, 1997, AS SUPPLEMENTED BY                  File No. 333-34087
PROSPECTUS SUPPLEMENTS DATED OCTOBER 1, 1997

                          CMS ENERGY CORPORATION

    General Term Notes (servicemark of J.W. Korth & Company), Series D
                Due 9 Months to 25 Years from date of issue

     Pursuant to the terms of a Distribution Agreement as supplemented by
certain letter agreements, the Company has appointed the Agents referred
to below as agents through which General Term Notes (servicemark of J.W.
Korth & Company) (the "Notes") may be offered by the Company on a
continuous basis.  Additional Agents may be designated under the
Distribution Agreement from time to time.  Except as set forth herein, the
Notes offered hereby have such terms as are described in the accompanying
Prospectus dated September 17, 1997, as supplemented by the Prospectus
Supplements dated October 1, 1997.

Aggregate Principal Amount:             $ 60,000.00
Original Issue Date 
  (Settlement Date):                    September 9, 1998
Stated Maturity Date:                   August 15, 2003
Issue Price to Public:                  100.00% of Principal Amount
Interest Rate:                          6.250% Per Annum
Interest Payment Dates:                 October 15 and monthly thereafter
                                        Commencing October 15, 1998
Survivor's Option:                      [ X ] Yes   [   ] No
Optional Redemption:                    [ X ] Yes   [   ] No

Initial Redemption Date:                August 15, 2000
Redemption Price:                       100% 

                                        Principal Amount of Notes
           Agent                        Solicited by Each Agent

Prudential Securities Incorporated      $  7,000.00
First of Michigan Corporation           $ 15,000.00
J.W. Korth & Company                    $ 38,000.00
           Total                        $ 60,000.00

                                        Per Note Sold by
                                        Agents To Public        Total

Issue Price:                            $  1,000.00         $ 60,000.00
Agent's Discount or Commission:         $      6.00         $    360.00
Maximum Dealer's Discount or
  Selling Concession:                   $     12.50         $    750.00
Proceeds to the Company:                $    981.50         $ 58,890.00

CUSIP Number:  12589QZK5
AGENDA

Advisory Board on Radiation and Worker Health 

Metals and Controls Corp. Workgroup Meeting 

May 12, 2023 

Videoconference:

Join ZoomGov Meeting 

https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09

Teleconference:

Phone: +1 646 828 7666 (U.S. East Coast) 

 Phone: +1 669 254 5252 (U.S. West Coast)

Meeting ID: 160 6763 3819 

Passcode: 98685439

11:00 a.m. (Eastern Time) Start

Welcome and roll-call

1. SCA-TR-2022-SEC002, “Supplemental Review of M&C Work Group Issues.” 

2. NIOSH response and WG discussion 

3. Carryover items from March 2021 M&C WG Meeting and SC&A Presentation on 

remaining issues with exposure pathway modeling: 

i. SCA-TR-2021-SEC004, “Metals and Controls Corp. Exposure Pathway 

Evaluation” 

ii. SCA-TR-2021-SEC005, “SC&A Commentary on NIOSH’s Approach to 

Quantifying Outdoor and Indoor Airborne Dust Loadings,” 

4. NIOSH Presentation/Response and WG discussion 

5. Petitioner comments (optional to Petitioner)

6. WG discussion of path forward: 

i. August Board meeting plans, if applicable 

ii. Follow-up actions 

Adjourn
Exhibit
32.02





Section
906, Certification of the CFO





CERTIFICATION
OF PERIODIC FINANCIAL REPORT


PURSUANT
TO 18 U.S.C. SECTION 1350





Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned officer of ServisFirst Bancshares,
Inc. (the “Company”) certifies that, to his knowledge, the Quarterly Report on
Form 10-Q of the Company for the quarter ended September 30, 2010, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and information contained in the Report fairly presents, in
all material respects, the financial condition and results of operation of the
Company.





Date:
      November 1, 2010
                  By:
                  /s/ William M. FosheeWilliam
      M. FosheeChief
      Financial Officer





A signed
original of this written statement has been provided to the registrant and will
be retained by the registrant and furnished to the Securities and Exchange
Commission or its staff upon request.
AGENDA 

Advisory Board on Radiation and Worker Health 

Meeting of the

Fernald WG

June 17, 2013

Cincinnati Airport Marriott 

2395 Progress Dr., Hebron, KY 41048 

(859)-586-0166

Conference Phone: 1-866-659-0537; Participant Code: 9933701#

9:00 a.m. (Eastern Time) Welcome and roll-call/introductions

Work Group Discussion 

1. Intro/Background (progress since 3/7/2013 WG meeting)

2. Uranium bioassay coworker model for subcontractors during pre-1986 period (SEC Issue #1)

3. Thorium -232 coworker model based on DWE reports for 1953-1967 period (SEC issue 6a)

4. Thorium-232 coworker model based on chest count data for 1978-1988 period; implementation

6. Additional SEC or site profile issues 

7. WG conclusions/recommendations

8. Preparations for July ABRWH meeting/follow-up actions

Adjourn
Exhibit 32.1




CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report on Form 10-Q (the “Report”) of BioNeutral Group, Inc. (the “Corporation”) for the quarter ended April 30, 2010, as filed with the Securities and Exchange Commission on the date hereof, I, Stephen Browand, Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.





Dated: June 14, 2010
/s/ Stephen BrowandName: Stephen BrowandTitle: Chief Executive Officer

(Principal Executive Officer and Principal Financial Officer)





The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.





A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Corporation and will be retained by the Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
Order entered February 13, 2017

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-16-01112-CV

IN THE INTEREST OF G.B., A CHILD

On Appeal from the 304th Judicial District Court

Dallas County, Texas

Trial Court Cause No. JD-98-00657

ORDER

Before the Court is appellant’s February 10, 2017 motion for extension of time to file 

appellant’s supplemental brief. We GRANT appellant’s motion.

We ORDER the supplemental brief received on January 11, 2017 filed as of the date of 

this order.

/s/ ELIZABETH LANG-MIERS 

JUSTICE
Baker Brothers Special 

Exposure Cohort

Petition Evaluation Report 

Update

Dr. Paul Zeimer 

July 2013
Petition History

 June 5,2012: NIOSH received 83.13 petition for 1943 

through 1996

 July 24, 2012: Petition qualified for evaluation

 November 14, 2012: Evaluation Report approved

 December 12, 2012: NIOSH proposes SEC Class for 

Operating Period 1943–1944 

 January 31, 2013: ABRWH recommends proposed SEC 

class to HHS

 January – June 2013: TBD-6000 Work Group reviews 

dose reconstruction feasibility for residual period 
BAKER BROTHERS BACKGROUND

 Location – Toledo, OH

 Atomic Weapons Employer (AWE) 1943–1944; 

Residual radiation 1945–1994 and 1996; DOE 

remediation 1995

 Between June 1943 and July 1944, duPont and 

University of Chicago subcontracted Baker Brothers to 

machine uranium rods into slugs used to fuel reactors 

in Oak Ridge, TN, and Hanford, WA 
RESIDUAL PERIOD - PROPOSED 

NIOSH APPROACH 

 At start of residual period use TBD-6000 generic 

machining operator to define airborne uranium 

concentration (GM – 5,480 dpm/m3) 

 Assume 30 days deposition and settling velocity of 

7.5e-04 m/s 

 Surface concentration – 5,480 dpm/m3 × 7.5e-04 m/s × 

30 days × 86,400 s/day = 10,653,120 dpm/m2 

 Assume exponential decay per OTIB-0070
RESIDUAL PERIOD - PROPOSED 

NIOSH APPROACH 

 NIOSH concluded that doses can be reconstructed 

during the residual period

 This conclusion has been re-examined by the 

TBD-6000 Work Group
Potential SEC Problem for Residual 

Period

 Uranium fires were common occurrences during the 

operating period

 Uranium fires could cause elevated surface 

concentrations as compared to TBD-6000 approach 

especially if no clean-up occurred at end of operating 

period
Resolution of Problem

 Data from Adley et al. 1952 show that airborne 

concentrations during U machining fires are lower 

than values for generic machining operator based on 

TBD-6000

 TBD- 6000 machining operator – 5,480 dpm/m3

(DWA) versus Adley machinists – 182 to 2,340 dpm/m3 
TBD 6000 Work Group Conclusion

 Doses during the residual period can be reconstructed 

with sufficient accuracy as proposed by NIOSH

 No change to SEC is required 
References

 Adley, F.E., W.E. Gill, and R.H. Scott, 1952. Study of 

Atmospheric Contamination in the Melt Plant Building, 

USAEC report HW-233352 (Rev.), April 4, 1952.

 TBD-6000. Site Profiles for Atomic Weapons 

Employers that Worked Uranium Metals. BattelleTBD-6000. Rev. 01. National Institute for 

Occupational Safety and Health (NIOSH); Cincinnati, 

Ohio; Division of Compensation Analysis and Support 

(DCAS); effective June 17, 2011; SRDB Ref ID: 101251.
---

EXHIBIT 32.1

|CERTIFICATION PURSUANT TO                     
|----------------------------------------------
|18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
|SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

I, Rui Yang, hereby certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

|(1) | the Quarterly Report on Form 10-Q of Future Canada China
      Environment Inc. for the period ended May 31, 2009 (the "Report") fully
      complies with the requirements of Section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                                                                                                        
|(2) | the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of Future Canada China Environment Inc.                                                               

Dated: July 20, 2009

| | /s/ Rui Yang                                                   
| | ---------------------------------------------------------------
| | RUI YANG                                                       
| | President, Secretary, Treasurer and Director                   
| | (Principal Executive Officer, Principal
      Financial Officer
| | and Principal Accounting Officer)                              
| | Future Canada China Environment Inc.                           

A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Future Canada
China Environment Inc. and will be retained by Future Canada China Environment
Inc. and furnished to the Securities and Exchange Commission or its staff upon
request.

---
| (1)   | the      quarterly Report on Form 10-Q of Granto, Inc. for the quarter ended June      30, 2008 fully complies with the requirements of Section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | the      information contained in the quarterly Report on Form 10-Q for the quarter      ended June 30, 2008, fairly presents in all material respects, the      financial condition and results of operations of Granto,    Inc. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/ Rosalinda      Ritualo                                                      |
|--------|---------------------------------------------------------------------------------|
| Name:  | Rosalinda      Ritualo                                                          |
| Title: | Principal      Executive Officer, Principal      Financial Officer and Director |
| Date:  | July      23, 2008                                                              |
EXHIBIT 23.1





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the incorporation by reference of our report dated June 21, 2022, relating to our audit of the L3Harris Retirement Savings Plan’s financial statements and supplemental schedule as of and for the year ended December 31, 2021, which appears in this Annual Report on Form 11-K in Registration Statement No. 333-222821 on Form S-8.


/s/ Buchbinder Tunick & Company LLP


Bethesda, MD


June 21, 2022
|        |
|--------|
|        |  |
|   |   |
| 1.     | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|   |   |
| 2.     | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

|        |
|--------|
|        |  |  |
|   |   |   |
|   | /s/ JOHN C. HEINMILLER |   |
|   | John C. Heinmiller |   |
|   | Executive Vice President and |   |
|   | Chief Financial Officer |   |
|   | August 7, 2012 |   |
Exhibit 99.1


               STATEMENT UNDER OATH OF PRINCIPAL EXECUTIVE OFFICER
                        REGARDING FACTS AND CIRCUMSTANCES
                        RELATING TO EXCHANGE ACT FILINGS

     I, Stephen R. Wright, state and attest that:

     (1) To the best of my knowledge, based upon a review of the covered reports
of Pro-Fac  Cooperative,  Inc.,  and,  except as corrected or  supplemented in a
subsequent covered report:

          o    no covered report contained an untrue statement of a material
               fact as of the end of the period covered by such report (or in
               the case of a report on Form 8-K or definitive proxy materials,
               as of the date on which it was filed); and

          o    no covered report omitted to state a material fact necessary to
               make the statements in the covered report, in light of the
               circumstances under which they were made, not misleading as of
               the end of the period covered by such report (or in the case of a
               report on Form 8-K or definitive proxy materials, as of the date
               on which it was filed).

     (2) I have reviewed the contents of this statement with the Company's audit
committee.

     (3) In this statement under oath, each of the following, if filed on or
before the date of this statement, is a "covered report":

          o    the Annual Report on Form 10-K of Pro-Fac  Cooperative,  Inc. for
               the fiscal year ended June 29, 2002;

          o    all  reports  on Form  10-Q,  all  reports  on  Form  8-K and all
               definitive  proxy  materials of Pro-Fac  Cooperative,  Inc. filed
               with the  Commission  subsequent  to the  filing of the Form 10-K
               identified above; and

          o    any amendments to any of the foregoing.


/s/ Stephen R. Wright                     Subscribed and sworn to
Stephen R. Wright                         before me this 2nd  day of
General Manager and Secretary             October, 2002.
(Principal Executive Officer)             Julia H. McMaster
Dated October 2, 2002                     Notary Public

                                          My Commission Expires: April 30, 2006
REGISTRANTS:
    /s/ Thomas S. Gayner Date:
    /s/ Kenneth Eich Date:
   /s/ Douglas Haines Date:
   
   /s/ Marc P. Blum Date:
  /s/ Andrew A. Davis Date:
  /s/ Christopher C. Davis Date:
  /s/ John Gates Date:
  /s/ Thomas S. Gayner Date:
  /s/ Samuel H. Iapalucci Date:
  /s/ Robert P. Morgenthau Date:
  /s/ Marsha Williams Date:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel, “The Mucosal Immune Barrier''.                    

*Date:*                         February 27, 2008.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6700B Rockledge Drive, Rm. 3256, Bethesda, MD 20817 (Telephone Conference Call).                    

*Contact Person:*                         Ileana M. Ponce-Gonzalez, MD, MPH, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 451-3679,                         *ipgonzalez@niaid.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: January 25, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-432  Filed 1-31-08; 8:45 am]

BILLING CODE 4140-01-M
EXHIBIT 23INDEPENDENTAUDITORS’ CONSENT
We consent to theincorporation by reference in Registration Statement No. 333-54710 ofWilshire Financial Services Group Inc. on Form S-8 of our report datedApril 14, 2004 (which expresses an unqualified opinion and includesexplanatory paragraphs relating to the Company’s adoption of Statement ofFinancial Accounting Standards No. 142, Goodwill and Other Intangible Assets,and to the restatement described in Notes 1 and 25) appearing in this Annual Report onForm 10-K of Wilshire Financial Services Group Inc. for the year endedDecember 31, 2003. 

DELOITTE & TOUCHE LLP
Portland, OregonApril 14, 2004
ABRWH

Weldon Spring Work Group

Action Items and Agenda

Cincinnati Airport Marriott Hotel

Teleconference Phone: 866-659-0537; Participant Code: 9933701

October 19, 2010

9:00 a.m. Welcome and introductions Katz

• Brief overview of Weldon Spring Site Evaluation Report and SEC status DCAS

• Issues Matrix for Weldon Spring Site Evaluation Report and SEC petition SCA

• Draft NIOSH response to SCA Issues Matrix DCAS

• Administrative detail and calendar